OR1A2
gene geneOn this page
Also known as OR17-6
Summary
OR1A2 (olfactory receptor family 1 subfamily A member 2, HGNC:8180) is a protein-coding gene on chromosome 17p13.3, encoding Olfactory receptor 1A2 (Q9Y585). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26189 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_012352
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8180 |
| Approved symbol | OR1A2 |
| Name | olfactory receptor family 1 subfamily A member 2 |
| Location | 17p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR17-6 |
| Ensembl gene | ENSG00000172150 |
| Ensembl biotype | protein_coding |
| OMIM | 618047 |
| Entrez | 26189 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000381951
RefSeq mRNA: 1 — MANE Select: NM_012352
NM_012352
CCDS: CCDS11021
Canonical transcript exons
ENST00000381951 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001490369 | 3197519 | 3198448 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 78.38.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.38 | silver quality |
| hair follicle | UBERON:0002073 | 61.06 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 59.99 | gold quality |
| decidua | UBERON:0002450 | 59.58 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| placenta | UBERON:0001987 | 33.34 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 28.01 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| blood | UBERON:0000178 | 26.49 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| leukocyte | CL:0000738 | 26.08 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| mononuclear cell | CL:0000842 | 25.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| calcaneal tendon | UBERON:0003701 | 25.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Evolutionary conserved amino acid residues to be necessary for specific responsiveness of OR1A1 to odorants were identified. (PMID:17601748)
- We identified and confirmed a novel region on OR1A2 associated with Neuroticism. (PMID:23903073)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or1a1b | ENSMUSG00000070377 |
| mus_musculus | Or1a1 | ENSMUSG00000070378 |
| rattus_norvegicus | Or1a1 | ENSRNOG00000087148 |
| rattus_norvegicus | Or1a1b | ENSRNOG00000087980 |
Paralogs (130): OR1I1 (ENSG00000094661), OR12D3 (ENSG00000112462), OR7A10 (ENSG00000127515), OR7C2 (ENSG00000127529), OR7C1 (ENSG00000127530), OR1E2 (ENSG00000127780), OR1J1 (ENSG00000136834), OR1L4 (ENSG00000136939), OR4D1 (ENSG00000141194), OR4K1 (ENSG00000155249), OR3A3 (ENSG00000159961), OR7G1 (ENSG00000161807), OR1Q1 (ENSG00000165202), OR1K1 (ENSG00000165204), OR4K2 (ENSG00000165762), OR4D6 (ENSG00000166884), OR1F1 (ENSG00000168124), OR4K14 (ENSG00000169484), OR4K15 (ENSG00000169488), OR7G3 (ENSG00000170920), OR7G2 (ENSG00000170923), OR1M1 (ENSG00000170929), OR4D5 (ENSG00000171014), OR1L6 (ENSG00000171459), OR1L3 (ENSG00000171481), OR1L8 (ENSG00000171496), OR1N2 (ENSG00000171501), OR1N1 (ENSG00000171505), OR2AT4 (ENSG00000171561), OR1A1 (ENSG00000172146), OR4C11 (ENSG00000172188), OR4X2 (ENSG00000172208), OR4D9 (ENSG00000172742), OR10K1 (ENSG00000173285), OR1L1 (ENSG00000173679), OR7D4 (ENSG00000174667), OR4S2 (ENSG00000174982), OR4B1 (ENSG00000175619), OR4D11 (ENSG00000176200), OR4K17 (ENSG00000176230)
Protein
Protein identifiers
Olfactory receptor 1A2 — Q9Y585 (reviewed: Q9Y585)
Alternative names: Olfactory receptor 17-6, Olfactory receptor OR17-10
All UniProt accessions (2): Q9Y585, A0A126GVH4
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_036484* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 4, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y585-F1 | 88.32 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 43 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS, GOBP_REGULATION_OF_CELL_DIVISION, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOBP_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_CELL_DIVISION, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE
GO Biological Process (5): signal transduction (GO:0007165), positive regulation of cytokinesis (GO:0032467), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| cytokinesis | 1 |
| regulation of cytokinesis | 1 |
| positive regulation of cell division | 1 |
| positive regulation of cell cycle process | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
282 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR1A2 | KRTAP9-7 | A8MTY7 | 544 |
| OR1A2 | KRTAP9-8 | Q9BYQ0 | 446 |
| OR1A2 | KRTAP9-1 | A8MXZ3 | 410 |
| OR1A2 | RTP1 | P59025 | 375 |
| OR1A2 | NKAIN2 | Q5VXU1 | 373 |
| OR1A2 | RTP2 | Q5QGT7 | 370 |
| OR1A2 | TMEM95 | Q3KNT9 | 370 |
| OR1A2 | TMEM220 | Q6QAJ8 | 348 |
| OR1A2 | C17orf50 | Q8WW18 | 338 |
| OR1A2 | TAS2R13 | Q9NYV9 | 324 |
| OR1A2 | TBC1D3K | A0A087X1G2 | 321 |
| OR1A2 | TMEM181 | Q9P2C4 | 311 |
| OR1A2 | CDRT15L2 | A8MXV6 | 297 |
| OR1A2 | TMEM92 | Q6UXU6 | 292 |
| OR1A2 | TBC1D3H | P0C7X1 | 255 |
IntAct
1 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR1A2 | EMC8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): EMC8 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), EMC4 (Affinity Capture-MS)
ESM2 similar proteins: A6NDH6, A6NDL8, A6NET4, A6NHG9, A6NKK0, A6NMS3, P0DN80, P23268, P34982, P35898, Q60887, Q60892, Q7TRF3, Q7TS48, Q8NG80, Q8NG85, Q8NGA0, Q8NGE2, Q8NGF7, Q8NGI8, Q8NGL4, Q8NGS5, Q8NGU1, Q8NGU2, Q8NGV6, Q8NGV7, Q8NGY2, Q8NGY6, Q8NGY9, Q8NH16, Q8NH92, Q8NHB7, Q8NHB8, Q8NHC5, Q8NHC6, Q8NHC7, Q8VEX5, Q8VEX6, Q8VF13, Q8VFB9
Diamond homologs: A3KFT3, A6NH00, A6NM03, O43749, O43869, O95006, O95371, O95918, P0C7N1, P0C7N5, P0C7T2, P0DN81, P23274, P23275, P30955, P34984, P47890, P58181, P70526, Q13607, Q5TZ20, Q60880, Q6IEZ7, Q6IF00, Q6UXT6, Q8N349, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG95, Q8NG97, Q8NGF4, Q8NGH3, Q8NGQ1, Q8NGR2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 6 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
381 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:3198271:T:TA | acceptor_gain | 0.7500 |
| 17:3197564:G:GT | donor_gain | 0.7200 |
| 17:3197781:G:T | donor_gain | 0.7000 |
| 17:3198340:GAT:G | donor_gain | 0.7000 |
| 17:3197574:G:GG | donor_gain | 0.6900 |
| 17:3198171:TTCA:T | acceptor_loss | 0.6900 |
| 17:3198173:CAGG:C | acceptor_loss | 0.6900 |
| 17:3198174:AGGT:A | acceptor_loss | 0.6900 |
| 17:3197573:A:AG | donor_gain | 0.6800 |
| 17:3197781:G:GT | donor_gain | 0.6800 |
| 17:3198169:T:G | acceptor_gain | 0.6800 |
| 17:3198267:ATTAT:A | acceptor_gain | 0.6700 |
| 17:3198383:A:AG | acceptor_gain | 0.6700 |
| 17:3198384:G:GG | acceptor_gain | 0.6700 |
| 17:3197564:G:T | donor_gain | 0.6500 |
| 17:3198277:AAC:A | acceptor_gain | 0.6500 |
| 17:3198343:G:GG | donor_gain | 0.6400 |
| 17:3197805:G:GT | donor_gain | 0.6300 |
| 17:3197694:T:G | donor_gain | 0.6200 |
| 17:3198279:C:CA | acceptor_gain | 0.6200 |
| 17:3198338:GTGAT:G | donor_gain | 0.6200 |
| 17:3198384:GTCT:G | acceptor_gain | 0.6200 |
| 17:3198270:AT:A | acceptor_gain | 0.6100 |
| 17:3197589:A:AG | donor_gain | 0.6000 |
| 17:3197606:A:AG | donor_gain | 0.6000 |
| 17:3197721:T:A | acceptor_gain | 0.5900 |
| 17:3198187:A:AG | acceptor_gain | 0.5900 |
| 17:3198188:G:GG | acceptor_gain | 0.5900 |
| 17:3198254:G:GG | donor_gain | 0.5900 |
| 17:3197575:TCAGC:T | donor_gain | 0.5800 |
AlphaMissense
2046 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:3198020:T:C | F168L | 0.923 |
| 17:3198022:C:A | F168L | 0.923 |
| 17:3198022:C:G | F168L | 0.923 |
| 17:3198047:T:C | F177L | 0.865 |
| 17:3198049:C:A | F177L | 0.865 |
| 17:3198049:C:G | F177L | 0.865 |
| 17:3197552:T:C | F12L | 0.863 |
| 17:3197554:T:A | F12L | 0.863 |
| 17:3197554:T:G | F12L | 0.863 |
| 17:3197852:A:C | S112R | 0.805 |
| 17:3197854:C:A | S112R | 0.805 |
| 17:3197854:C:G | S112R | 0.805 |
| 17:3197818:G:C | Q100H | 0.800 |
| 17:3197818:G:T | Q100H | 0.800 |
| 17:3198072:T:C | L185P | 0.798 |
| 17:3198383:A:C | S289R | 0.795 |
| 17:3198385:T:A | S289R | 0.795 |
| 17:3198385:T:G | S289R | 0.795 |
| 17:3198053:T:A | C179S | 0.780 |
| 17:3198054:G:C | C179S | 0.780 |
| 17:3198069:T:C | L184S | 0.780 |
| 17:3197553:T:C | F12S | 0.770 |
| 17:3198021:T:G | F168C | 0.762 |
| 17:3197615:T:C | C33R | 0.751 |
| 17:3197609:T:C | F31L | 0.750 |
| 17:3197611:T:A | F31L | 0.750 |
| 17:3197611:T:G | F31L | 0.750 |
| 17:3197963:T:A | W149R | 0.728 |
| 17:3197963:T:C | W149R | 0.728 |
| 17:3197553:T:G | F12C | 0.724 |
dbSNP variants (sampled 300 via entrez): RS1000481817 (17:3197286 C>A), RS1001140574 (17:3198776 A>G), RS1001805176 (17:3196259 T>A,G), RS1003629333 (17:3196466 T>C), RS1005762278 (17:3196755 C>G,T), RS1006355699 (17:3195551 A>G), RS1006440504 (17:3198130 C>T), RS1007154656 (17:3195859 A>G), RS1007855885 (17:3198701 G>A,C), RS1008914345 (17:3196886 T>C), RS1009233439 (17:3197210 G>A,C), RS1009287223 (17:3197424 T>A), RS1009869610 (17:3195891 G>A,C,T), RS1010334536 (17:3195622 A>G), RS1013049355 (17:3197726 G>A)
Disease associations
OMIM: gene MIM:618047 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| citronellal | affects binding, increases expression | 3 |
| citronellol | affects binding | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Camptothecin | decreases response to substance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.